Credit: Richard OD/Shutterstock.com
Nomad Foods plans to close its Rorschach manufacturing plant in Switzerland by the end of the year as part of the European frozen-food group’s savings plan.
In a statement, the UK-headquartered owner of the Birds Eye, Iglo and Findus brands said the proposed move is aligned with its “long-term productivity programme” unveiled last year.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The closure would affect 45 full-time employees, with consultations with staff running until 8 May.
As outlined in September, Nomad Foods is targeting €200m ($233.1m) in operational savings over its 2026 to 2028 financial years, with efficiencies expected across procurement, logistics and overheads.
At the time, the company said the savings would be “broad-based”, although the biggest contribution is set to come from a procurement transformation programme.
It is also looking to improve utilisation across its manufacturing network, reduce logistics costs and unlock overhead efficiencies.
Nomad Foods believes the savings will allow the business to make “targeted reinvestments” and “mitigate” pressure from inflation.
Production currently carried out at Rorschach, including frozen meals such as Plätzli, lasagne and cannelloni sold under the Findus brand in Switzerland, would be transferred to other facilities in Italy and Spain.
Eduardo Bachiega, Nomad Foods’ chief supply officer, said: “This is a very difficult decision and over the coming months we will work closely with all affected employees to provide support throughout this transition.”
The company said supply to the Swiss market would not be disrupted.
The announcement comes as Nomad Foods navigates a challenging trading environment.
Two months ago, chief executive Dominic Brisby, who took over in January, described the business as being in a “transition year” marked by “some near-term turbulence”.
In 2025, organic sales fell 1.9% to €3bn, with volumes down 1.4% and price/mix slipping 0.5%.
Reported revenue declined 2.2%. For 2026, the company expects organic sales to fall by a further 2-5%.
Adjusted EBITDA is forecast to decline 5-10%, after falling 7.5% in 2025, while adjusted EPS is expected to drop 4-13%, compared to a 6.7% decline last year.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.